(Q48095120)

8 February 2018

title

Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans. (English)

1 reference

8 February 2018

0 references

1

1 reference

8 February 2018

Taisuke Tomita

8

1 reference

8 February 2018

author name string

Arai H

2

1 reference

8 February 2018

Higuchi M

3

1 reference

8 February 2018

Tashiro M

4

1 reference

8 February 2018

Matsui T

5

1 reference

8 February 2018

Itoh M

6

1 reference

8 February 2018

Iwatsubo T

7

1 reference

8 February 2018

Sasaki H

9

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

8 February 2018

published in

Neuroscience Letters

1 reference

8 February 2018

volume

273

1 reference

8 February 2018

issue

3

1 reference

8 February 2018

page(s)

203-207

1 reference

8 February 2018

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900644-8

7 January 2021

10.1016/S0304-3940(99)00644-8

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10515194

1 reference

8 February 2018